Les moteurs et les freins au développement des médicaments génériques
Appreciated for their price but in many cases neglected, the generical drugs try to penetrate the pharmaceutical landscape. Our analysis focuses on several legal and strategic mechanisms which either encourage or curb their development on the market. Beyond these mechanisms, it is especially a mentality change, encouraged by a balanced dialog between health professionals and consumers, which has to be implemented.
Volume (Year): L (2011)
Issue (Month): 1 ()
|Contact details of provider:|| Web page: http://www.cairn.info/revue-reflets-et-perspectives-de-la-vie-economique.htm|
When requesting a correction, please mention this item's handle: RePEc:cai:rpvedb:rpve_501_0141. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Jean-Baptiste de Vathaire)
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If references are entirely missing, you can add them using this form.
If the full references list an item that is present in RePEc, but the system did not link to it, you can help with this form.
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your profile, as there may be some citations waiting for confirmation.
Please note that corrections may take a couple of weeks to filter through the various RePEc services.